Davita (DVA)

DaVita, Inc. (DVA) is the largest provider of dialysis services to patients suffering from End-Stage Renal Disease (ESRD), and a major operator of integrated dialysis centers. The company provides services through approximately 1,300 outpatient dialysis centers located in 42 states and the District of Columbia, serving approximately 104,000 patients. Separate from providing outpatient dialysis services, the company also provides acute inpatient dialysis services to nearly 300 hospitals. As an additional part of its core business, the company offers ESRD laboratory services, disease management services, and administrative services. DaVita is based in El Segundo, California, and employs more than 13,500 people. Direct dialysis services, including the administration of pharmaceuticals during dialysis treatments, currently represent approximately 96% of total revenues, with lab services, management fees, disease management services and research programs accounting for the balance. Approximately 60% of total dialysis revenues are derived from government-based programs, principally Medicare and Medicaid, with the balance from more than 600 commercial payors under more than 1,500 commercial healthcare plans and approximately 300 managed-care contracts. Approximately 50% of total dialysis revenues are associated with Medicare patients, which represent nearly 70% of total patients.

On October 5, 2005, DVA completed the acquisition of the U.S. dialysis clinics division of Swedish healthcare company, Gambro AB, for 20.5 billion kronor ($3.055B).

Read full report on DaVita Inc

Company overview provided by

Company Products/Services/Markets:

Enter Company Products/Services Here

Strategy:

Describe Key Aspects of Company's Strategy Here

Competitors:

Enter Competitors Here

Industry Trends and News:

Enter Industry Trends and News Here

Acquisitions, Divestitures, Major Transactions, Spin-offs :

Enter Acquisitions, Divestiures, Major Transactions, Spin-offs Here

Management – Pros & Cons, Changes:

Enter Management - Pros & Cons, Changes Here

Buy Rationale:

Enter Buy Rationale Here

Sell Rationale:

Enter Sell Rationale Here